Heron Therapeutics Inc. [HRTX] Sees 3,571 Share Insider Sell From EVP, COO Szekeres David Leslie
On Jan. 08, Szekeres David Leslie divested U.S. $70,219 in shares of Heron Therapeutics Inc.. The EVP, COO sold 3,571 shares at a price per share of $19.66. The transaction decreased this specific insider’s holdings to 0 shares worth around $0.0 at present. Guggenheim launched its Heron Therapeutics Inc. [HRTX] rating to the equivalent of […]
